These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24482954)

  • 1. A case of deadly "TEN".
    Tripathy A; Lakshmanan I; Lakshmanan A; Lakshmanan SS
    J Assoc Physicians India; 2013 May; 61(5):348-50. PubMed ID: 24482954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D; From L; Ricciatti D; Shapero H
    Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
    de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
    Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft-versus-host disease or toxic epidermal necrolysis: diagnostic dilemma after liver transplantation.
    Jeanmonod P; Hubbuch M; Grünhage F; Meiser A; Rass K; Schilling MK; Kollmar O
    Transpl Infect Dis; 2012 Aug; 14(4):422-6. PubMed ID: 22650490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options.
    Worswick S; Cotliar J
    Dermatol Ther; 2011; 24(2):207-18. PubMed ID: 21410610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
    Sane SP; Bhatt AD
    J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purpura Fulminans in Toxic Epidermal Necrolysis: Case Report and Review.
    Jones E; Stair-Buchmann M; Kotliar S; Haith L
    J Burn Care Res; 2015; 36(6):e274-82. PubMed ID: 25412057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction].
    Rabelink NM; Brakman M; Maartense E; Bril H; Bakker-Wensveen CA; Bavinck JN
    Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2089-94. PubMed ID: 14619195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stevens-Johnson syndrome and toxic epidermal necrolysis in children].
    Sotelo-Cruz N
    Gac Med Mex; 2012; 148(3):265-75. PubMed ID: 22820360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature.
    Yildirim Cetin G; Sayar H; Ozkan F; Kurtulus S; Kesici F; Sayarlioglu M
    Lupus; 2013 Jul; 22(8):839-46. PubMed ID: 23761100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical factors differentiating erythema multiforme majus from Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN).
    Watanabe R; Watanabe H; Sotozono C; Kokaze A; Iijima M
    Eur J Dermatol; 2011; 21(6):889-94. PubMed ID: 21873140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens-Johnson syndrome and toxic epidermal necrolysis: oncologic considerations.
    Hockett KC
    Clin J Oncol Nurs; 2004 Feb; 8(1):27-30, 55. PubMed ID: 14983759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options.
    Teo L; Tay YK; Liu TT; Kwok C
    Singapore Med J; 2009 Jan; 50(1):29-33. PubMed ID: 19224081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Treat J
    Pediatr Ann; 2010 Oct; 39(10):667-9, 672-4. PubMed ID: 20954613
    [No Abstract]   [Full Text] [Related]  

  • 16. [Toxic epidermal necrolysis (syndrome Lyell) versus Stevens-Johnson syndrome].
    Jezierska-Krupa B; Hyla-Klekot L
    Pediatr Pol; 1996 Jul; 71(7):615-20. PubMed ID: 8803466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel induced Lyell's syndrome: a rare life threatening cause of dermatitis medicamentosas.
    Arshad F; Bhat TS; Lone AR
    J Cancer Res Ther; 2014; 10(3):742-4. PubMed ID: 25313773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostication Using SCORTEN Severity of Illness Score in Patients With Stevens Johnson Syndrome and Toxic Epidermal Necrolysis.
    Seecof OM; Liantonio J
    J Pain Symptom Manage; 2019 Jan; 57(1):e8-e9. PubMed ID: 30273718
    [No Abstract]   [Full Text] [Related]  

  • 20. Intestinal involvement in toxic epidermal necrolysis. A case report and review of literature.
    Fava P; Astrua C; Cavaliere G; Brizio M; Savoia P; Quaglino P; Fierro MT
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1843-5. PubMed ID: 24754517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.